• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

FDA

Posted inDrug Safety, Metabolism, Regulatory

Febuxostat in Treatment of Gout: Walk With Death

by Julia Mardi April 7, 2021September 8, 2022

A popular antigout drug Uloric carries increased risks of death.

Insomnia.
Posted inNeuroscience, New Drugs, Regulatory

Dayvigo: New Japanese Drug for Insomnia

by Mark Gubar April 4, 2021September 8, 2022

Lemborexant by Eisai to help you fall asleep. Chronic sleep loss, go away!

Suicide.
Posted inDrug Safety, Regulatory

Montelukast Drives Patients to Suicide

by Julia Mardi April 1, 2021September 8, 2022

A popular asthma and allergy drug Singulair can make you lose your mind.

Multiple sclerosis.
Posted inAutoimmune Diseases, Neuroscience, New Drugs, Regulatory

Mayzent: New Drug for Treatment of Secondary Progressive Multiple Sclerosis

by Tanya von Reuss April 1, 2021September 8, 2022

Siponimod released by Novartis is an improved version of Gilenya.

Posted inNew Drugs, Oncology, Regulatory

Enhertu: Most Powerful Drug to Treat Advanced HER2-Positive Breast Cancer

by Mark Gubar March 31, 2021September 8, 2022

Trastuzumab deruxtecan, developed by AstraZeneca and Daiichi Sankyo, will save lives when Herceptin, Perjeta, and Kadcyla haven’t worked.

heart
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory

Arcalyst: World’s First Drug to Treat Recurrent Pericarditis

by Tanya von Reuss March 30, 2021September 8, 2022

Rilonacept by Kiniksa Pharmaceuticals will reduce recurrent pericarditis to almost nothing.

Posts pagination

Newer posts 1 … 9 10 11
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×